


The 1945-65 birth cohort carries a sixfold higher prevalence of chronic hepatitis C than other age groups and accounts for approximately 75% of U.S. HCV infections, with an estimated 800,000 cases still undiagnosed. Metabolic dysfunction-associated steatotic liver disease has become the most prevalent etiology of chronic liver disease in older adults and the leading transplant indication for patients over 65, while cirrhosis prevalence among Medicare Advantage enrollees reached 1.67% in 2018, more than double the commercially insured rate. Because chronic hepatitis is frequently silent until advanced fibrosis develops, accurate etiology-specific coding and fibrosis staging are essential to timely, effective care.
AAVBC's Chronic Hepatitis Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 coding specificity across viral, autoimmune, alcohol-related, and drug-induced etiologies, universal HCV and HBV screening protocols, age-adjusted FIB-4 fibrosis staging, hepatocellular carcinoma surveillance criteria, MEAT documentation standards, first-line antiviral and MASH therapies, and comorbidity management. Grounded in AASLD, CDC, and USPSTF guidance, this guide supports consistent, individualized clinical decision-making, helping care teams close screening-to-treatment gaps and stage fibrosis accurately, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of chronic hepatitis — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.


The 1945-65 birth cohort carries a sixfold higher prevalence of chronic hepatitis C than other age groups and accounts for approximately 75% of U.S. HCV infections, with an estimated 800,000 cases still undiagnosed. Metabolic dysfunction-associated steatotic liver disease has become the most prevalent etiology of chronic liver disease in older adults and the leading transplant indication for patients over 65, while cirrhosis prevalence among Medicare Advantage enrollees reached 1.67% in 2018, more than double the commercially insured rate. Because chronic hepatitis is frequently silent until advanced fibrosis develops, accurate etiology-specific coding and fibrosis staging are essential to timely, effective care.
AAVBC's Chronic Hepatitis Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 coding specificity across viral, autoimmune, alcohol-related, and drug-induced etiologies, universal HCV and HBV screening protocols, age-adjusted FIB-4 fibrosis staging, hepatocellular carcinoma surveillance criteria, MEAT documentation standards, first-line antiviral and MASH therapies, and comorbidity management. Grounded in AASLD, CDC, and USPSTF guidance, this guide supports consistent, individualized clinical decision-making, helping care teams close screening-to-treatment gaps and stage fibrosis accurately, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of chronic hepatitis — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.